October 31, 2013—A federal district judge has approved the federal government’s and drug manufacturers’ joint motion to speed up the industry’s lawsuit challenging the legality of the 340B orphan drug exclusion regulation.
You must be registered to read complete articles (it's quick, easy, and 100% free). Click here to register. Already registered? Click here to login. (340B Health members, Drug Discount Monitor subscribers, and 340B Coalition conference attendees: Use your existing username and password.)